Description
RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE
First action · last action
2020-01-24 · 2021-03-12
Transactions
2
First transaction's obligation
$206,043
Base + all options value (sum of deltas)
$156,329
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25219D0033
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-01-24+$206,043= $206,043
- Mod P000012021-03-12-$49,714= $156,329
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-01-24 | +$206,043 | $206,043 | RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2021-03-12 | −$49,714 | $156,329 | RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EQ4VSLH8RC33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0411 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $231,773 | FY2026 |
| 36C24126N0274 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $771,411 | FY2026 |
| 36C25226N0210 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $164,999 | FY2026 |
| 36C26126N0065 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $153,991 | FY2026 |
| 36C24825N0208 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $224,563 | FY2025 |
| 36C24125N0495 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $656,883 | FY2025 |
Other recipients under 6550 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226F0375 | ABBOTT LABORATORIES INC. | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $38,016 | FY2026 |
| 36C25226N0484 | FISHER SCIENTIFIC COMPANY L.L.C. | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $28,264 | FY2026 |
| 36C25226N0438 | BECTON, DICKINSON AND COMPANY | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $21,300 | FY2026 |
| 36C25226F0238 | ABBOTT LABORATORIES INC. | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $31,680 | FY2026 |
| 36C25226N0266 | BIOMERIEUX INC | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $65,900 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25220N0186_3600_36C25219D0033_3600 · retrieved 2026-09-26.